Eli Lilly and Company

Indianapolis, Indiana

Classification

Public

Financials

Revenue & Profit

Revenue

Valuation

Valuation

Ratios

Revenue / EBITDA
$123 MM
Valuation / Revenue
$123 MM
Valuation / Employees
$123 MM
EBITDA / Revenue
$123 MM
1-Year CAGR (Revenue)
03
3-Year CAGR (Revenue)
11
1-Year CAGR (Employees)
19
3-Year CAGR (Employees)
96

People

Employee Figures

Employees

Key Executives

NameTitleSocialsEmailPhone
John DoeEmployee
--
Jane DoeEmployee
John DoeEmployee
John DoeEmployee

401K

Total Active Participants
1234
No. Participants with Account Balances
56789
Total Liabilities Start of Year
1234
Total Assets Start of Year
56789

Deals

M&A2024-03-15Completed

Seller

Founders Group

Investor Sponsors

NorthBridge PE

Deal Amount

$120M

Target Company Valuation

$1.20 MM

Techniques

Acquisition of Assets, Taken Private

Stake Tags

100%

Is PE deal

Yes

Is deal PE backed

Yes

Total Acquired

100%

Secondary Transaction2023-09-01Canceled

Target

BrightHealth Technologies

Seller

Early Investors Consortium

Investor Sponsors

--

Deal Amount

Undisclosed

Target Company Valuation

NaN

Techniques

Secondary Sale, Management Buy-out (MBO)

Stake Tags

Majority

Is PE deal

No

Is deal PE backed

Yes

Total Acquired

65%

Funding

About

About

Eli Lilly and Company is a global pharmaceutical corporation dedicated to discovering, developing, and delivering innovative medicines to improve people's lives around the world. With a legacy spanning over a century, the company remains committed to its core values of excellence, integrity, and respect for people. Eli Lilly focuses on therapeutic areas such as oncology, diabetes, immunology, neuroscience, and cardiovascular diseases, leveraging its expertise in research and development to address unmet medical needs and advance healthcare solutions. Product/Service Line Breakdown: 1. Oncology Therapeutics: Developing novel cancer treatments targeting various types of cancers. 2. Diabetes Care: Providing medications and solutions for the management of diabetes and related complications. 3. Immunology Products: Offering therapies for autoimmune diseases and related disorders. 4. Neuroscience Medications: Developing treatments for neurological conditions, including Alzheimer's disease and migraine. 5. Cardiovascular Pharmaceuticals: Producing medications for heart diseases and related conditions. 6. Animal Health Products: Providing a range of veterinary medicines and services that cater to the well-being of companion animals and livestock.

Keywords

Keywords

Classified

Private